- Home
- ILMN vs TTWO Comparison
ILMN vs TTWO Comparison
Compare ILMN & TTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- TTWO
- Stock Information
- Founded
- ILMN 1998
- TTWO 1993
- Country
- ILMN United States
- TTWO United States
- Employees
- ILMN N/A
- TTWO N/A
- Industry
- ILMN Medical Specialities
- TTWO Computer Software: Prepackaged Software
- Sector
- ILMN Health Care
- TTWO Technology
- Exchange
- ILMN Nasdaq
- TTWO Nasdaq
- Market Cap
- ILMN 23.6B
- TTWO 32.6B
- IPO Year
- ILMN 2000
- TTWO 1997
- Fundamental
- Price
- ILMN $134.96
- TTWO $187.16
- Analyst Decision
- ILMN Buy
- TTWO Strong Buy
- Analyst Count
- ILMN 17
- TTWO 20
- Target Price
- ILMN $163.12
- TTWO $200.11
- AVG Volume (30 Days)
- ILMN 2.1M
- TTWO 1.4M
- Earning Date
- ILMN 02-06-2025
- TTWO 02-06-2025
- Dividend Yield
- ILMN N/A
- TTWO N/A
- EPS Growth
- ILMN N/A
- TTWO N/A
- EPS
- ILMN N/A
- TTWO N/A
- Revenue
- ILMN $4,390,000,000.00
- TTWO $5,457,000,000.00
- Revenue This Year
- ILMN N/A
- TTWO $7.24
- Revenue Next Year
- ILMN $4.05
- TTWO $45.83
- P/E Ratio
- ILMN N/A
- TTWO N/A
- Revenue Growth
- ILMN N/A
- TTWO 0.35
- 52 Week Low
- ILMN $97.36
- TTWO $135.24
- 52 Week High
- ILMN $156.66
- TTWO $191.91
- Technical
- Relative Strength Index (RSI)
- ILMN 40.09
- TTWO 57.87
- Support Level
- ILMN $130.31
- TTWO $179.00
- Resistance Level
- ILMN $137.69
- TTWO $188.40
- Average True Range (ATR)
- ILMN 5.13
- TTWO 3.54
- MACD
- ILMN -1.03
- TTWO -0.99
- Stochastic Oscillator
- ILMN 21.69
- TTWO 63.21
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About TTWO Take-Two Interactive Software Inc.
Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.